SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 10.64 |
| Enterprise Value ($M) | 13.20 |
| Book Value ($M) | 4.79 |
| Book Value / Share | 0.94 |
| Price / Book | 2.22 |
| NCAV ($M) | -0.06 |
| NCAV / Share | -0.01 |
| Price / NCAV | -166.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.98 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.67 |
| Current Ratio | 1.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.07 |
| Assets | 27.93 |
| Liabilities | 23.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 34.07 |
| Operating Income | -21.35 |
| Net Income | -20.13 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -24.89 |
| Cash from Investing | 0.62 |
| Cash from Financing | 8.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Lytton Laurence W | 9.99 | ||
| 13G | Rosalind Advisors, Inc. | 9.90 | ||
| 13G | Hirschman Orin | 9.90 | ||
| 13G | Bigger Capital, LLC | 9.99 | ||
| 13G | Armistice Capital, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,359 | 96,360 | 9.71 | |
| 21,361 | 12,563 | 170.03 | |
| 42,996 | 47,491 | 90.54 | |
| 17,567 | 6,506 | 270.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BCLI – Brainstorm Cell Therapeutics Inc. | BCTX – BriaCell Therapeutics Corp. |
| BFRG – Bullfrog AI Holdings, Inc. | BGXX – Bright Green Corporation |
| BIVI – BioVie Inc. |
Financial data and stock pages provided by
Fintel.io